loader

ladenburg thalmann

LATEST ARTICLES

Eyenovia Announces Pricing of Initial Public Offering

UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option

Pharmaceutical Investing

UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares

Pharmaceutical Investing

Catalyst Announces Pricing of $18 Million Public Offering

Cellectar Biosciences Announces Pricing of $8,000,000 Public Offering

Nektar Therapeutics Prices Public Offering of Shares of Common Stock

Stemline Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference

ParkerVision Closes $3 Million Private Placement of Common Stock

BioTime, Inc. Announces Pricing of Public Offering of Common Stock

Ignyta Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

ADMA Biologics Announces Pricing of Public Offering of Common Stock

Cellectar Biosciences Announces Successful Completion of $8 Million Public Offering

Latest News

More News